# Delineating mechanisms underlying azole-induced developmental toxicity using single cell transcriptomic approaches, genome editing tools, and alternative models

> **NIH NIH R01** · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2022 · $715,222

## Abstract

Summary
Azoles are antifungal agents widely-used in clinical applications and agriculture. Despite evident exposures in
humans, the developmental health risks associated with azole exposures during pregnancy remains undefined.
In vertebrate models, azoles cause developmental toxicity, including a spectrum of congenital malformations.
While the mechanisms are unresolved, azoles induce changes in the embryo that resemble excess
bioavailability of all-trans retinoic acid (RA) due to similarities in adverse morphological and molecular
phenotypes. In a spatiotemporal-dependent manner, RA regulates the transcription of hundreds of genes,
several with known essential functions for embryonic development. Many environmental chemicals are
suspected to cause developmental toxicity by disrupting RA signaling at different points in the pathway. As we
transition towards alternative, animal-free approaches for developmental toxicity testing, delineating
toxicological mechanisms associated with perturbations in key signaling pathways such as RA is warranted to
establish appropriate in vitro and in silico testing models for identifying chemical hazards. In this project, we
propose to leverage alternative models for developmental toxicity testing: rat whole embryo culture (WEC; Aim
1), zebrafish (Zf; Aim 2) embryo, and human embryonic stem cell (hESC; Aim 3) models and innovative
molecular tools (e.g., single-cell RNA sequencing, CRISPR-Cas9), to investigate mechanisms linked with
azole-induced developmental toxicity during a predefined susceptible window in embryogenesis (early
organogenesis). We will determine conserved molecular, cellular, and morphological changes due to azole
exposure and functional targets with roles in cell proliferation, differentiation and patterning. Results will be
used to delineate an adverse outcome pathway (AOP) of azole-induced developmental toxicity. Finally, our
study will be one of the first investigations to implement single-cell transcriptomics and multi-gene editing to
link chemical exposures to adverse developmental outcomes on molecular, cellular and organism levels.

## Key facts

- **NIH application ID:** 10337968
- **Project number:** 1R01ES033617-01
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- **Principal Investigator:** Joshua Frederick Robinson
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $715,222
- **Award type:** 1
- **Project period:** 2022-03-04 → 2026-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10337968

## Citation

> US National Institutes of Health, RePORTER application 10337968, Delineating mechanisms underlying azole-induced developmental toxicity using single cell transcriptomic approaches, genome editing tools, and alternative models (1R01ES033617-01). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10337968. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*